{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-026821","form_type":"8-K","ticker":"XRN","cik":"0001533615","company_name":"Chiron Real Estate Inc.","filed_at":"2023-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.430258+00:00","generated_at":"2026-06-18T22:01:08.097058+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Global Medical REIT Q4 net income falls to $0.01 EPS; revenue up 19.6% to $36.3M","bullets":["Q4 net income $0.4M ($0.01 diluted EPS) vs $3.8M ($0.06) YoY; AFFO flat at $0.24/share.","Full-year FFO $64.0M ($0.92/share) vs $58.2M ($0.90); AFFO $68.0M ($0.98) vs $61.4M ($0.95).","Completed 14 acquisitions totaling $148.9M at 7.4% cap rate; sold one property for $17.9M (gain $6.8M).","Leverage increased to 47.6% (from 43.0% year-end 2021); weighted avg interest rate 4.20%, up from 2.88% in Q4'21.","Q4 dividend $0.21/share common, unchanged; no ATM issuances in Q4."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-026821","json":"https://secwatch.observer/filing/0001104659-23-026821.json","markdown":"https://secwatch.observer/filing/0001104659-23-026821.md","text":"https://secwatch.observer/filing/0001104659-23-026821.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533615/000110465923026821/0001104659-23-026821-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533615/000110465923026821/tm238074d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T22:01:08.097058+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25d37fe121eb7b2618982a9b1a8c083bd68502f5","claim":"Chiron Real Estate Inc. reported the twelve months ended December 31, 2022 results: revenue $137.3 million, net income $13.3 million, EPS $0.20 per diluted share.","evidence_excerpt":"or $0.98 per share and unit, as compared to $61.4 million, or $0.95 per share and unit, in the comparable prior year period. · Increased total revenue 18.4% year-over-year to $137.3 million, primarily driven by the Company’s acquisition activity since the comparable prior year period. · Completed 14 acquisitions encompassing an aggregate 583,253 leasable square","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533615/000110465923026821/0001104659-23-026821-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the twelve months ended December 31, 2022"},{"label":"Revenue","value":"$137.3 million"},{"label":"Net income","value":"$13.3 million"},{"label":"EPS","value":"$0.20 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"ac3c582e683ca638c67502b3912be316286b9aa6","claim":"Chiron Real Estate Inc. reported the three months ended December 31, 2022 results: revenue $36.3 million, net income $0.4 million, EPS $0.01 per diluted share.","evidence_excerpt":"or $0.24 per share and unit, as compared to $16.4 million, or $0.24 per share and unit, in the comparable prior year period. · Increased total revenue 19.6% year-over-year to $36.3 million, primarily driven by the Company’s acquisition activity since the comparable prior year period. Full Year 2022 Highlights · Net income attributable to common stockholders was","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533615/000110465923026821/0001104659-23-026821-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended December 31, 2022"},{"label":"Revenue","value":"$36.3 million"},{"label":"Net income","value":"$0.4 million"},{"label":"EPS","value":"$0.01 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}